977 related articles for article (PubMed ID: 24336068)
1. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
Barsoum IB; Smallwood CA; Siemens DR; Graham CH
Cancer Res; 2014 Feb; 74(3):665-74. PubMed ID: 24336068
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide.
Barsoum IB; Hamilton TK; Li X; Cotechini T; Miles EA; Siemens DR; Graham CH
Cancer Res; 2011 Dec; 71(24):7433-41. PubMed ID: 22006996
[TBL] [Abstract][Full Text] [Related]
3. Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis.
Black M; Barsoum IB; Truesdell P; Cotechini T; Macdonald-Goodfellow SK; Petroff M; Siemens DR; Koti M; Craig AW; Graham CH
Oncotarget; 2016 Mar; 7(9):10557-67. PubMed ID: 26859684
[TBL] [Abstract][Full Text] [Related]
4. The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis.
Noman MZ; Buart S; Van Pelt J; Richon C; Hasmim M; Leleu N; Suchorska WM; Jalil A; Lecluse Y; El Hage F; Giuliani M; Pichon C; Azzarone B; Mazure N; Romero P; Mami-Chouaib F; Chouaib S
J Immunol; 2009 Mar; 182(6):3510-21. PubMed ID: 19265129
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms Of Hypoxia-Induced Immune Escape In Cancer And Their Regulation By Nitric Oxide.
Graham C; Barsoum I; Kim J; Black M; Siemens RD
Redox Biol; 2015 Aug; 5():417. PubMed ID: 28162279
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PD-L1: a novel role of pro-survival signalling in cancer.
Chen J; Jiang CC; Jin L; Zhang XD
Ann Oncol; 2016 Mar; 27(3):409-16. PubMed ID: 26681673
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction.
Abiko K; Mandai M; Hamanishi J; Yoshioka Y; Matsumura N; Baba T; Yamaguchi K; Murakami R; Yamamoto A; Kharma B; Kosaka K; Konishi I
Clin Cancer Res; 2013 Mar; 19(6):1363-74. PubMed ID: 23340297
[TBL] [Abstract][Full Text] [Related]
8. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.
Blank C; Kuball J; Voelkl S; Wiendl H; Becker B; Walter B; Majdic O; Gajewski TF; Theobald M; Andreesen R; Mackensen A
Int J Cancer; 2006 Jul; 119(2):317-27. PubMed ID: 16482562
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
Chen N; Fang W; Zhan J; Hong S; Tang Y; Kang S; Zhang Y; He X; Zhou T; Qin T; Huang Y; Yi X; Zhang L
J Thorac Oncol; 2015 Jun; 10(6):910-23. PubMed ID: 25658629
[TBL] [Abstract][Full Text] [Related]
10. Targeting the PD1/PD-L1 axis in melanoma: biological rationale, clinical challenges and opportunities.
Merelli B; Massi D; Cattaneo L; Mandalà M
Crit Rev Oncol Hematol; 2014 Jan; 89(1):140-65. PubMed ID: 24029602
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.
Chen J; Feng Y; Lu L; Wang H; Dai L; Li Y; Zhang P
Immunobiology; 2012 Apr; 217(4):385-93. PubMed ID: 22204817
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hypoxia-inducible factor 1α accumulation by glyceryl trinitrate and cyclic guanosine monophosphate.
Kim J; Barsoum IB; Loh H; Paré JF; Siemens DR; Graham CH
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912870
[TBL] [Abstract][Full Text] [Related]
13. Gain of HIF-1α under normoxia in cancer mediates immune adaptation through the AKT/ERK and VEGFA axes.
Lee YH; Bae HC; Noh KH; Song KH; Ye SK; Mao CP; Lee KM; Wu TC; Kim TW
Clin Cancer Res; 2015 Mar; 21(6):1438-46. PubMed ID: 25589622
[TBL] [Abstract][Full Text] [Related]
14. High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
Chang YL; Yang CY; Lin MW; Wu CT; Yang PC
Eur J Cancer; 2016 Jun; 60():125-35. PubMed ID: 27107327
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide.
Siemens DR; Hu N; Sheikhi AK; Chung E; Frederiksen LJ; Pross H; Graham CH
Cancer Res; 2008 Jun; 68(12):4746-53. PubMed ID: 18559521
[TBL] [Abstract][Full Text] [Related]
16. Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance.
Wang YH; Cao YW; Yang XC; Niu HT; Sun LJ; Wang XS; Liu J
Asian Pac J Cancer Prev; 2014; 15(3):1321-6. PubMed ID: 24606459
[TBL] [Abstract][Full Text] [Related]
17. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
[TBL] [Abstract][Full Text] [Related]
18. [The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response].
Zatloukalová P; Pjechová M; Babčanová S; Hupp TR; Vojtěšek B
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):72-77. PubMed ID: 27846724
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells.
Noman MZ; Buart S; Romero P; Ketari S; Janji B; Mari B; Mami-Chouaib F; Chouaib S
Cancer Res; 2012 Sep; 72(18):4629-41. PubMed ID: 22962263
[TBL] [Abstract][Full Text] [Related]
20. HUVECs affect HuT-78 cell apoptosis and cytokine production via the HIF-1α-PD-L1/PD-1 pathway under hypoxia.
Qiang L; Hong L; Jian X; Zhanlin Z
Int Immunopharmacol; 2023 May; 118():110010. PubMed ID: 36924563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
